In this paper we give an overview of government regulations in the national drug markets of the European Community. We describe the admission of new medicines to the market, the organisation of the distribution system, the control of pharmaceutical prices, and the patient copayment schemes for...

Unfavorable news are often delivered under the disguise of vagueness. Our theory-driven laboratory experiment investigates this strategic use of vagueness in voluntary disclosure and asks whether there is scope for policy to improve information transmission. We find that vagueness is profitably...